Skip to content

Clinical trials

Observational Autism Spectrum Disorder trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Observational Country / region: United Kingdom Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20171
20181
20222
20232
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Not yet recruiting3
Unknown status3
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brightlobe Limited1
East Suffolk and North Essex NHS Foundation Trust1
Elizabeth Kilbey1
Great Ormond Street Hospital for Children NHS Foundation Trust1
King's College London1
Life University1
Little Journey1
Liverpool John Moores University1
Ottawa Hospital Research Institute1
Royal Devon and Exeter NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder14
Attention Deficit Disorder with Hyperactivity5
Autistic Disorder5
Intellectual Disability2
Neurodevelopmental Disorders2
Asthma1
COVID-191
Death1
Dyslexia1
Epilepsy1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.